Detalhe da pesquisa
1.
Effective elimination of high-dose methotrexate by repeated hemodiafiltration and high-flux hemodialysis in patients with acute kidney injury.
J Oncol Pharm Pract
; 28(2): 508-515, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34668443
2.
Daratumumab for relapsed AL amyloidosis-When cumulative real-world data precedes clinical trials: A multisite study and systematic literature review.
Eur J Haematol
; 106(2): 184-195, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33090552
3.
Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study.
Ann Hematol
; 99(6): 1273-1281, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32193630
4.
Immunogenicity and SARS-CoV-2 Infection following the Fourth BNT162b2 Booster Dose among Health Care Workers.
Vaccines (Basel)
; 11(2)2023 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851161
5.
Immunogenicity trends 1 and 3 months after second BNT162B2 vaccination among healthcare workers in Israel.
Clin Microbiol Infect
; 28(3): 450.e1-450.e4, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838782
6.
Third BNT162b2 Vaccine Booster Dose against SARS-CoV-2-Induced Antibody Response among Healthcare Workers.
Vaccines (Basel)
; 10(10)2022 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36298606